Latest News
The preliminary result of EMA inspection of Trogarzo production in SBL

Source: TaiMed Biologics


The European Medicines Agency's (EMA) inspection of TaiMed new AIDS drug Trogarzo for commercial production scale-up in Samsung Biologics (SBL) has been completed on June 1, 2021.

The company was notified by Samsung Biotechnology (SBL) today that there were no critical and major deficiencies in the factory inspection, and it should be smooth.

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
©Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:16F.-1, No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978